EMEA-000117-PIP01-07-M07

Key facts

Invented name
Yervoy
Active substance
Ipilimumab
Therapeutic area
Oncology
Decision number
P/0085/2015
PIP number
EMEA-000117-PIP01-07-M07
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of all conditions included in the category of malignant neoplasms (except melanoma, nervous system, haematopoietic and lymphoid tissue)
Route(s) of administration
Intravenous use
Contact for public enquiries
Bristol-Myers Squibb Pharma EEIG
United Kingdom
E-mail: medical.information@bms.com
Tel. +44 (0)1895 523740
Fax +44 (0)1895 523677
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000117-PIP01-07-M07
Compliance opinion date
11/12/2015
Compliance outcome
positive

Decision

How useful was this page?

Add your rating